SPDR S&P Pharmaceuticals ETF
XPH
XPH
64 hedge funds and large institutions have $116M invested in SPDR S&P Pharmaceuticals ETF in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
32% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 25
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
64
Holding in Top 10
–
Calls
$783K
Puts
$1.12M
Top Buyers
| 1 | +$1.94M | |
| 2 | +$1.93M | |
| 3 | +$1.14M | |
| 4 |
SW
SVB Wealth
Boston,
Massachusetts
|
+$328K |
| 5 |
EWA
EP Wealth Advisors
Torrance,
California
|
+$278K |
Top Sellers
| 1 | -$1.6M | |
| 2 | -$1.5M | |
| 3 | -$959K | |
| 4 |
CI
CX Institutional
Auburn,
Indiana
|
-$745K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$737K |
